Insys Faces $18M Bill For Final Stretch Of Founder's Trial
Insys Therapeutics may have to shell out over $18 million in legal costs for founder John Kapoor for the first quarter of 2019, the final stretch of a lengthy racketeering trial...To view the full article, register now.
Already a subscriber? Click here to view full article